


CV Therapeutics
Biotechnology Research • Palo Alto, California, United States • 201-500 Employees
Company overview
| Headquarters | 3172 Porter Drive, Palo Alto, CA 94304, US |
| Website | |
| NAICS | 541714 |
| Founded | 1991 |
| Employees | 201-500 |
| Socials |
Key Contacts at CV Therapeutics
Michael Locker
Medical Director
Beth Layug
Assoc. Director
Nancy Chu
Associate Director
Kenny Crouch
Director, Sales
Wisnu Hidayat
Ceo
Gordon Petrie
Sr Director Of Finance
Tekin Memhet
Ceo
Melvin Tarver
Region Director
Max Nygaard
Regulatory Affairs Associate Director
Ardian Ian
Small Business Owner
CV Therapeutics Email Formats
CV Therapeutics uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 54.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 54.7% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 19.2% |
{last name}.{first name}@company.com | doe.john@company.com | 11.3% |
{first name}@company.com | john@company.com | 9.1% |
{first name}{last name}@company.com | johndoe@company.com | 5.7% |
About CV Therapeutics
CV Therapeutics, Inc. is a biopharmaceutical company headquartered in Palo Alto, CA. Focused on the development of novel small molecule therapeutics for the treatment of cardiovascular diseases, CV Therapeutics has emerged as a leader in cardiovascular medicine. In April 2009, CV Therapeutics was acquired by Gilead Sciences, Inc.
CV Therapeutics revenue & valuation
| Annual revenue | $300,000,000 |
| Revenue per employee | $703,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $960,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
CV Therapeutics has 131 employees across 16 departments.
Departments
Number of employees
Frequently asked questions
4.8
40,000 users



